- Live market news
- Stocks
- ONCY
Oncolytics Biotech Inc.
ONCYStockUnited States
0.4488USD+0.0288 (+6.86%)Live · 5 Nov, 20:59 UTC
About
Oncolytics Biotech Inc.
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
Key figures
- Previous close
- 0.42
- Open
- 0.43
- Day range
- 0.3841 – 0.455
- 52-week range
- —
- Volume
- 2.86M
Latest news on ONCYranked by Oyticker for market impact
In detailthe same figures as in Oyticker Charts
Performance
1D+6.9%
Ranges & volume
Day0.3841 – 0.455
52 weeks—
- Open
- 0.43
- Prev. close
- 0.42
Volume 2.86Mavg —
Risk · 1 year
Not enough historyRisk needs at least a month of daily sessions.
Seasonality
Not enough historySeasonality needs several months of data.
SEC filings
All its filingsWhat ONCY filed
- 9 Nov 2026
- 4 Nov 2026
- 27 Oct 2026
- 20 Oct 2026
- 14 Oct 2026
- 13 Oct 2026
- 6 Oct 2026
- 29 Sept 2026
- 28 Sept 2026
- 10 Sept 2026
- 18 Aug 2026
- 12 Aug 2026
- 24 Jul 2026
- 20 Jul 2026
- 13 Jul 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.